TriSalus Life Sciences, Inc. Amortization of Intangible Assets
TriSalus Life Sciences, Inc. (TLSI) reported Amortization of Intangible Assets of $13.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2024-08-14
- TriSalus Life Sciences, Inc. amortization of intangible assets for the quarter ending 2024-06-30 was $0.00.
- TriSalus Life Sciences, Inc. amortization of intangible assets for the quarter ending 2024-03-31 was $13.00K, a 40.91% decline year-over-year.
- TriSalus Life Sciences, Inc. amortization of intangible assets for the quarter ending 2023-06-30 was $0.00.
- TriSalus Life Sciences, Inc. amortization of intangible assets for the quarter ending 2023-03-31 was $22.00K.
- TriSalus Life Sciences, Inc. amortization of intangible assets for fiscal 2023 was $18.00K, a 85.25% decline from fiscal 2022.
- TriSalus Life Sciences, Inc. amortization of intangible assets for fiscal 2022 was $122.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $13.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $13.00K 10-Q · filed 2024-05-15 | ||
| 2023-12-31 | $18.00K 10-K · filed 2024-04-11 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $22.00K 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $22.00K 10-Q · filed 2024-05-15 | ||
| 2022-12-31 | $122.00K 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |